This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group (UNH) Q3 Earnings Beat, Boosts '23 EPS View
by Zacks Equity Research
UnitedHealth Group's (UNH) management presently forecasts adjusted net EPS between $24.85 and $25.00 for 2023.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Compared to Estimates, UnitedHealth (UNH) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for UnitedHealth (UNH) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
UnitedHealth Group (UNH) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 3.63% and 1.02%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Dow ETF in Focus Ahead of Q3 Earnings
by Sweta Killa
With some of the blue-chip companies having reasonable chances of coming up with an earnings surprise, investors should closely monitor the movement of the Dow ETF and grab any opportunity that arises from a surge in any of the 30 stocks.
Is a Surprise Coming for UnitedHealth (UNH) This Earnings Season?
by Zacks Equity Research
UnitedHealth (UNH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Analyst Blog UnitedHealth, Chevron, AstraZeneca, Adobe and Pfizer
by Zacks Equity Research
UnitedHealth, Chevron, AstraZeneca, Adobe and Pfizer are part of the Zacks Analyst Blog.
3 Stocks to Buy for Strong Dividend Growth
by Derek Lewis
Consistent dividend hikes reflect a company's successful nature, opting to share profits with shareholders. And that's precisely what these three companies have done.
Top Analyst Reports for UnitedHealth, Chevron & AstraZeneca
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Chevron Corporation (CVX) and AstraZeneca PLC (AZN).
Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q3 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) third-quarter results are expected to benefit from an increase in UnitedHealthcare's Community & State revenues as well as the number of people it served.
Can High Medical Costs Affect UnitedHealth (UNH) Q3 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) third-quarter results are likely to reflect growth in memberships and premium levels.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
3 Companies to Buy for Robust Cash Flows
by Derek Lewis
Companies boasting strong cash-generating abilities can be great investments, as they have plenty of cash to fuel growth, pay out dividends, and easily wipe out debt.
UnitedHealth Group (UNH) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $526.51, marking a +0.32% move from the previous day.
Soaring Tensions in Middle East Lead Investors Seeking Protection in Treasuries
by Mayur Thaker
And a September jobs report that looked impressive, but the devil's in the details.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Beat the Market the Zacks Way: UnitedHealth, Novo Nordisk, Check Point Software in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Zacks Investment Ideas feature highlights: PepsiCo, Delta Air Lines and UnitedHealth Group
by Zacks Equity Research
PepsiCo, Delta Air Lines and UnitedHealth Group are part of the Zacks Investment Ideas article.
3 Key Quarterly Releases to Watch Next Week
by Derek Lewis
The Q3 cycle will undoubtedly be a critical period, particularly as the market tries to extend impressive year-to-date gains. Are there any surprises lurking?
Here's Why You Should Hold UnitedHealth Group (UNH) Stock Now
by Zacks Equity Research
Growing Membership, expanding government business, strategic acquisitions, improving operating margin and solid 2024 plans poise UnitedHealth Group (UNH) well for growth.
UnitedHealth (UNH) Arm Optum Partners With ProHealth Care
by Zacks Equity Research
Per the deal, more than 800 employees of ProHealth Care are likely to shift to UnitedHealth's (UNH) Optum business.
Cigna (CI) Unveils 2024 Expansion Plans, Eyes Membership Growth
by Zacks Equity Research
Cigna (CI) declares the availability of a varied set of health plans across new counties in 2024. It, thereby, places intensified focus on growing its Medicare business.
UnitedHealth Group (UNH) Stock Moves -0.99%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $509.47, moving -0.99% from the previous trading session.
UnitedHealth Group (UNH) to Expand Coverage Area in 2024
by Zacks Equity Research
UnitedHealth Group (UNH) is set to enhance its offerings with UCard and expand to 110 new counties in 2024 with its Individual Medicare Advantage Plan.